Oct 10, 2023 Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology
Aug 30, 2023 Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 10, 2023 Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update
Aug 3, 2023 Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023
Jul 24, 2023 Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant
Jul 6, 2023 Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
Jun 28, 2023 Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update
Jun 22, 2023 Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023
Jun 21, 2023 Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation